I think that investors have relied on analyst reports (such as Roth & Edison) to put the trial result releases into perspective.
It would be interesting to know why VLA has ceased funding these reports. The target SP predictions have been a joke but the analysis has been quite good.
.
Ann: New Data at SITC Meeting. Further Studies Announced, page-89
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
